Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Profiling CD antigens on leukaemias with an antibody microarray.

Nicole Barber¹, Swetlana Gez, Larissa Belov

¹School of Molecular and Microbial Biosciences, University of Sydney, Sydney, NSW 2006, Australia.

|March 21, 2009

Summary

Cluster of differentiation (CD) antigens are key cell surface markers. DotScan microarrays rapidly profile these CD antigens for classifying leukaemia subtypes and identifying biomarkers in non-hematological diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Diagnostic accuracy of CRP and myeloperoxidase as a 2-marker biosignature for the diagnosis of symptomatic TB.

Scientific reports·2026

Same author

Oxygen-induced multimodal ultramicroporous structure in 10-nm-thick carbon membranes for enhanced hydrogen separation.

Nature communications·2026

Same author

Hypertension and CLL: a common and hazardous relationship.

Blood advances·2026

Same author

On the computability of biological machines.

Lancet (London, England)·2026

Same author

Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Blood·2026

Same author

To make biology programmable, we must master its generative grammar.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Area of Science:

Immunology
Biotechnology
Oncology

Background:

Cluster of differentiation (CD) antigens are cell surface molecules identified by specific antibodies.
Monoclonal antibodies targeting CD antigens are crucial for flow cytometry and cell-based assays.
Characterizing CD antigen expression aids in understanding cell function and disease states.

Purpose of the Study:

To introduce and validate the DotScan microarray technology for high-throughput CD antigen profiling.
To demonstrate the utility of DotScan for identifying cell surface marker signatures in various diseases.
To enable rapid and parallel characterization of CD antigen repertoires.

Main Methods:

Development of DotScan microarrays utilizing monoclonal antibodies against CD antigens.

More Related Videos

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing

Published on: September 25, 2011

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Application of fluorescence multiplexing for sensitive detection of CD antigens.

Profiling of CD antigen expression on leukocytes, colorectal cancer cells, and tumor-infiltrating lymphocytes.

Main Results:

DotScan microarrays allow rapid and parallel characterization of CD antigen expression patterns.
Expression profiles can be correlated with distinct subtypes of leukaemia.
Biomarker signatures for non-hematological diseases, including cancer, can be defined.
Profiling of minor cell subsets, like cancer cells, is achievable.

Conclusions:

DotScan technology offers a powerful tool for comprehensive CD antigen analysis.
This method facilitates the discovery of novel biomarkers for disease classification and diagnosis.
The technology has broad applications in hematological and non-hematological malignancies.